Literature DB >> 14580691

Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas.

Hui-Chun Chen1, Ricky Y Chu, Ping-Ning Hsu, Ping I Hsu, Jau-Yeong Lu, Kwok-Hung Lai, Hui-Hwa Tseng, Nan-Hua Chou, Ming-Shyan Huang, Ching-Jiunn Tseng, Michael Hsiao.   

Abstract

Perturbation in E-cadherin expression leads to loss of cellular adhesion with possible consequence of cellular transformation and tumor progression. The aims of this study were to determine E-cadherin expression in each subtype of gastric cancer classified by different classification systems, and to investigate the role of E-cadherin in cell differentiation, cancer invasion and metastasis. Expression of E-cadherin was analyzed in 84 patients with gastric adenocarcinoma by immunohistochemistry and correlated with clinicopahotlogical parameters. Our results showed loss of E-cadherin expression in 0% (0/3), 20.0% (9/45), 48% (15/31), 100% (3/3) and 100% (2/2) of papillary, tubular, poorly differentiated, signet-ring cell, and mucinous adenocarcinoma by Japanese histological classification. The reduction of E-cadherin expression was inversely correlated with the grade of differentiation. According to the histological classification of Lauren and Ming, the frequency of lost E-cadherin expression was higher in diffuse type (65%) and infiltrative type (64%) gastric cancer than in intestinal type (20%, P<0.001) and expanding type cancer (22%, P<0.001), respectively. The loss of E-cadherin expression was significantly associated with tumor invasion (P<0.05). Furthermore, there was a borderline association between the loss of E-cadherin expression and poor survival (P=0.109). These data demonstrated a striking correlation between E-cadherin expression and the differentiation of gastric carcinoma. The loss of E-cadherin expression may contribute to gastric cancer invasion to adjacent organs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14580691     DOI: 10.1016/j.canlet.2003.07.007

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  37 in total

1.  Analysis of metastasis suppressing function of E-cadherin in gastric cancer cells by RNAi.

Authors:  Zhi-Hong Zheng; Xiu-Ju Sun; Hai-Tao Zhou; Chao Shang; Hong Ji; Kai-Lai Sun
Journal:  World J Gastroenterol       Date:  2005-04-07       Impact factor: 5.742

2.  Adenocarcinoma of the stomach: a review.

Authors:  James M McLoughlin
Journal:  Proc (Bayl Univ Med Cent)       Date:  2004-10

3.  Tracking the transport of E-cadherin to and from the plasma membrane.

Authors:  Matthew P Wagoner; Kun Ling; Richard A Anderson
Journal:  Methods Mol Biol       Date:  2008

4.  Clinicopathological features of stomach cancer with invasive micropapillary component.

Authors:  Takeo Fujita; Naoto Gotohda; Yuichiro Kato; Takahiro Kinoshita; Shinichiro Takahashi; Masaru Konishi; Hiroyuki Daiko; Mitsuyo Nishimura; Takeshi Kuwata; Atsushi Ochiai; Taira Kinoshita
Journal:  Gastric Cancer       Date:  2011-10-12       Impact factor: 7.370

5.  Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.

Authors:  Yan-Ling Chen; Jun-Jiao Song; Xiao-Chun Chen; Wei Xu; Qiang Zhi; Yun-Peng Liu; Hong-Zhi Xu; Jin-Shui Pan; Jian-Lin Ren; Bayasi Guleng
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

6.  Frequent loss of membranous E-cadherin in gastric cancers: A cross-talk with Wnt in determining the fate of beta-catenin.

Authors:  Xiao-Xin Cheng; Zi-Chuang Wang; Xiao-Yan Chen; Yuan Sun; Qing-You Kong; Jia Liu; Xue Gao; Hong-Wei Guan; Hong Li
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  CDH1 promoter polymorphism (-347G-->GA) is a possible prognostic factor in sporadic colorectal cancer.

Authors:  Xiao-Ping Zou; Wei-Jie Dai; Jun Cao
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

8.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

9.  Highly efficient elimination of colorectal tumor-initiating cells by an EpCAM/CD3-bispecific antibody engaging human T cells.

Authors:  Ines Herrmann; Patrick A Baeuerle; Matthias Friedrich; Alexander Murr; Susanne Filusch; Dominik Rüttinger; Mariam W Majdoub; Sherven Sharma; Peter Kufer; Tobias Raum; Markus Münz
Journal:  PLoS One       Date:  2010-10-18       Impact factor: 3.240

10.  Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis.

Authors:  Weijie Yuan; Zhikang Chen; Shaobin Wu; Jie Ge; Shi Chang; Xianwei Wang; Jingxiang Chen; Zihua Chen
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.